University of Groningen Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine Martines, Anne-Claire
Hele tekst
(2) Chapter 4 The role of hepatic fatty-acid oxidation during cold stress: remodeling of hepatic metabolism in a mouse with medium-chain acyl-CoA dehydrogenase deficiency A.M.F. Martines1,#, Wenxuan Zhang1,2,#, Albert Gerding1,3, Maaike Goris4, Marcel de Vries1, Mirjam H. Koster1,4, Laura Bongiovanni5, Alain de Bruin1,5, Rob H. Henning4, Terry G. J. Derks1,6, Rainer Bischoff2, Dirk-Jan Reijngoud1,2, Barbara M. Bakker1,* #. Authors contributed equally to this work.. 1 Laboratory. of Pediatrics, Center of Liver, Digestive and Metabolic Diseases, University of Groningen, Groningen, University Medical Center Groningen, Groningen, The Netherlands, 2 Department of Analytical Biochemistry, University of Groningen, Groningen, The Netherlands 3 Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, The Netherlands 4 Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands 5 Department of Pathobiology, Faculty of Veterinary Medicine, Dutch Molecular Pathology Center, Utrecht University, The Netherlands 6 Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center of Groningen, University of Groningen.. Journal publication in preparation.
(3)
(4) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice. Abstract Ǧ ȾǦ ȋ Ȍ Ǧ Ǧ ȋȌ Ǧ Ǥ ǡ Ǧ ȋǦȌǦȋȌ ǤǦ ǡ ǡ Ǧ Ǧ Ǥ Ǧ Ǧ Ǥ Ǥ Ǧ ǡ ǡǡ Ǧ Ǧ Ǥ . ͳʹͻ. 4.
(5) Chapter 4. Introduction Ǧ Ǧ ȋ Ȍ Ǥ de novo ȏͳȂ ͵ȐǤǡ ȋ Ȍ ȏͳȂ͵ȐǤ Ǧ Ǧ ȋȌǤ Ǧ ȋȌ ȏͶǡͷȐǡ ǡ ȋ Ȍǡ ǡ ǦȏͳǡȂͻȐǤ ǡǦ ȋǦȌ ȏͳͲǡͳͳȐǤǦ Ǧ Ǧ ǡ ȏͳͲȐǤ ǡǦ ʹͶȏͳͲǡͳʹȐǤ ǡ ȋͶι Ȍ ǡȋȌ ȏͳͲȐǤ ǦǡǦǡǦǦ ǦȋǡȌ ȋȏͳ͵ȐȌǤ ǡ ȋȌ ǡ Ǧ ǡǦ ǦȏͳͶȂͳȐǤ Ǧ ȏͳȐǤ
(6) ǡ ȏͳͺȐ Ǧ ȏͳͻǡʹͲȐǤ
(7) ǡ Ǧ ȏʹͳȂʹ͵ȐǤ Ǧ ǡ Ǥde novo Ǥ ǡ Ǧ ȏʹͶȂʹȐǤǡ Ǧ ǡ ȏͳͲǡʹȐǤǡ Ǧ Ǥ
(8) ǡ Ǧ ͳͶ ʹͳ ι ͶǦͶιǤ ȋͺȌ ȋͳǦʹͲ ȌǤ ǡ Ǧ ǡǦ Ǥ Ǧ Ǧ ǡ Ǥ Ǧ Ǧ ȋͳͲǣͳȌ ǡ Ǥ
(9) Ǧ ȋ Ȍ ǦͳͶ ǡ Ǧ ȋȌ ȀǤ Ǧ Ǥ ͳ͵Ͳ.
(10) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice Ǥ . Results Young MCAD-KO mice are more vulnerable to cold exposure than adult MCAD-KO mice. ȋͳǦʹͲȌǦ ǡ ͳͶͶιǡ Ǥ ͶǦ Ͷͺ ǡ ȋ ͳȌǤ B. WT KO. 0 BF. AF. 2. 0. AF. *. 1.2 0.8 0.4 0.0. BF. AF. AFC. WT. 30. 20 20. WT KO. 0 BF. AF. 16-20 w .o. 5. AFC. BF. AF. AFC. *. 5. 16-20 w .o. 4. 3 3 0 WT KO. J. I 40. 30. Body weight (g). 40. 6. KO. H Rectal temperature ( qC). G. 10. F 1.6. 4. WT KO. 0. E Liver weight (g). Ketone bodies (mM). 25. BF. 6. Body temperature ( qC). 30. 20. AFC. D. 35. 30. 20 20 0. AFC. Rectal temperature ( qC). 20 20. 15. Blood glucose (mM). 30. C 40. i. Relative liver weight (%). i. 40. Body weight (g). Body temperature (qC). A. WT KO. 25. 20. 15 WT KO. BF. AF. 40. WT KO. 35 30. r=0.84 p<0.0001. 25. 8 w .o.. 20 20 0. AFC. 0. 10. 20. Body weight AF (g). L. i. *. 5. 0. 3 2 1. AF. AFC. *. 1.2 0.8 0.4 0.0. 0 BF. N 1.6. Liver weight (g). 10. Ketone bodies (mM). Blood glucose (mM). M 4. 15. BF. AF. AFC. WT. KO. Relative liver weight (%). K. 6. **. 5. 8 w .o.. 4. 3 3 0 WT. KO. Figure 1. Biometric results of 8- and 16-20-weeks-old mice. ǦȋA,GȌǡȋB,IȌǡ ȋC,KȌȋD,LȌ ȋ ȌǡͳͶǡ ȋ Ȍ ȋ ȌǡȋE,MȌȋΨȌȋF,NȌͳǦʹͲǦ ȋA-FȌ ͺ Ǧ ȋG,I,K-NȌ ȋHȌǡ ͳͶ ȋJȌ ͺǦ Ǧ Ǥ αǦͺ Ǥ ǡ Ǧ ͷΨ ͳǤͷȉǦ ȋ
(11) Ȍ ʹͷΨ ͳǤͷȉ
(12) Ǥ
(13) ǡiǣδͲǤͳǡȗǣδͲǤͲͷǡȗȗǣδͲǤͲͳǡȗȗȗǣδͲǤͲͲͳȗȗȗȗǣδͲǤͲͲͲͳ Ǥ Ǥ. . ͳ͵ͳ. 4.
(14) Chapter 4 Ǧ ǡ ȋ ͳȌǤ ǡǦ ȋ ͳȌǤ
(15) ǡ Ǧ ȋ ͳǦȌǤǡ ǡ Ǧ ȋ ͳǡ ȌǤ ǡ ͺǦǡǡ ǦǦ ȏͳͲȐǤ ͺ ǡǡ ȋͳȌǤǡ͵͵Ǥ͵ΨȋʹȀȌͳΨ ȋͷȀȌ ǡ ǡ ȋ ͳ ǡ Ǣ ͳȌǤ ȋ ͳ ǡ ȌǤ ǡ ǡǦ ȋ ͳ
(16) ȌǤ ȋ ͳ ͳȌǤ
(17) ǡ Ǧ Ǧ ȋ ͳȌǡ ȋ ͳȌǤǡ ǡǤǤ Ǥ ǡ ȋ ͲǦʹ Ȍǡ Ǥ ȋ ͳǡȌǡ Ǥ ǡ ǡ Ǧ Ǥ . Higher plasma acyl-carnitines and NEFAs in fasted, cold-exposed MCAD-KO mice ǡ Ǧ ǡ ǡ ȏʹͺȐǤ ͺ Ǧ ǡ ȽǦ ǡ Ǧȋ ʹʹȌǤǦ Ǧ ȏʹͻȂ͵͵ȐǤ
(18) ǡ Ǧ ͳͲǦ Ǧ Ǧ ǡ ȋ ʹǦʹǦȌǤ
(19) Ǧ ȏͳͲǡʹͺǡ͵ͶȐǡ ͳͲǣͳǤ ǡ ͺǦ Ǧ ȏʹͻȂ͵͵ȐǤ Ǧ ǡ ȋ ʹǦǡ ʹǦ ͳȌǤ ǡ Ǧ ȋ ʹȌǤ ȏ͵ͷȐǤ. ͳ͵ʹ.
(20) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice. [Blood amino acid] ( PM). A 1500. 1000. 500. Al an Ar ine As gin pa in ra e gi Cy ne G sti lu ne ta G ma lu ta te m G ine ly Hi cin s e Is tidi ol ne eu c Le ine uc in e M Lys Ph eth ine en ion yl in al e an in Pr e ol in Se e Th ri re ne Tr on yp in to e p Ty han ro si n Va e lin e. 0. Blood C n-acyl-carnitine ( PM). B. before fasting. C. 0.3. 0.3. ***. ***. 0.3. ****. 0.2. **. **. i. ** *. 0.1. 0.1. 0.0. 0.0 C6. C8. C10:1 C10. C12:1 C12. C6. after cold exposure. 0.4. ***. * 0.2. D. 14-hr fasted. 0.4. 0.4. 4. C8. C10:1 C10. C12:1 C12. 0.2. *** **. *. 0.1 0.0 C6. C8. C10:1 C10. C12:1 C12. E Serum NEFA (PM). 1500. **. 1000. 500. 0 16-20 w.o.. 8 w.o.. Figure 2. Blood metabolite concentrations. ȋAȌǡ Ǧ ȋB-DȌ ͺǦǦ ǡ ȋEȌǤ. ǡ ǡ Ǥ . Altered amino-acid and lipid handling in the liver of cold-exposed MCAD-KO mice ǡ ǡ Ǧ Ǥ Ǧ Ǥ
(21) ǡ Ǧ Ǧ Ǧ ȋ ͵ǡ ͵ ͳȌǤ Ǥ
(22) ǡ ǡ ǡ ǡ ǡ ǡ ǡ Ǧ ȋiǡδͲǤͳȌǡ ǡȽǦ Ǥ
(23) ǡ ǡ ȋ͵ǡȌǤ Ǧ ȋ ͵ǡ ͳȌǤ ǡ Ǧ Ǧ Ǧ ǡ ȏ͵ͶȐǤ. ͳ͵͵.
(24) Chapter 4. 8 6. i. **. **. *. ***. ** i. 4. **. 2. *. i. 0. Al an A ine As rgin i As par ne pa agi rti ne c a Cy cid s G tei G lut ne lu am ta m ine ic ac G id ly Hi cin s e Is tidi ol ne eu c Le ine uc in e M Lys Ph eth ine en ion yl in al e an in Pr e ol in S e Th eri re ne on Ty ine ro si n Va e lin e. [Liver amino acid] (nmol/g). A. C 1.0. 100. TG (P mol/g liver). Liver C n-acyl-carnitine (nmol/g). B 0.8 0.6 0.4 0.2 0.0. *. **. 80 60 40 20 0. C6. C8. C10:1 C10. C12:1 C12. 16-20 w.o.. 8 w.o.. Figure 3. Hepatic metabolite profiles.Ǧ ȋAȌǦͳʹ Ǧ ͺǦ ȋBȌǡ ȋ Ȍ ͳǦʹͲǦͺǦǦ ȋCȌǤ. ǡ ǦǦ ǡ Ǧ Ǥ ǡ ȋ Ȍ Ǧ ǡȋ ͵Ȍǡ Ǥ . Rerouting of medium-chain acyl-CoAs into chain-elongation and triglyceride synthesis Ǧ Ǧ Ǥǡ Ǥ ͲͲ ǡ ȋ Ͷ ʹȌǤ ȋȌ Ǧ ȋ ͶȌǤ Ǥ ȋδͲǤͲͷ εʹǢ Ͷ Ȍ ͵ͻ ǡͳ ǡͳȋ ʹȌǤ Ǧ ǡʹͶǦǡ ͶͲǦͶͺȋ ͶǦ ȌǤ ͳǤǡ Ǧ ͵ͳͶʹ Ǧ ȋ ǡ ͶǤ sn- Ǥͳ͵Ͳ ͳ ȋ͵ȌǤͻͷΨ Ǧ ͳͶǤʹΨ ͳͶ Ǧ ȋ Ͷ
(25) ȌǤ ǦtͳǤ ǦͳͲǤ. ͳ͵Ͷ.
(26) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice. B. A. C 10. -log (p-value). 5 0 -5 -10 -10. Total=624. 0. F. E. Liver TG (n.s.i. 106 ). TG(48:8). 5. 10. 100. ***. ****. 1.8. G ****. -5. 0. TG(42:2). 4. 5. DG(28:2) 1.5. ****. 1.2. 60. 2. H. 12. 80 1.0. 4. log2(fold change). TG(42:4). TG(44:2). 1.5. n.s. TG Other. 0 -5. PC1 (35%). D. 6. WT KO. PC2 (25.5%). TG (240) PC (124) DG (80) PE (49) SP (48) PS (18) CE (18) MG (13) PG (12) PI (11) CL (11). **** 1.0. 6 40. 0.5. 0.6. 0.5. 20 0.0 KO. I Number of isomers. 0.0. 0 WT. 0.0. 0 WT KO. WT KO. WT KO. WT KO. TG composition C6 C8 C9 C10 C12 C14 C15 C16 >C16. 100. 50. 0 c. b. a. Figure 4. Hepatic lipidomics profile of 8-weeks old mice. ȋAȌǡ ǡ ǡ ȋBȌǡ ȋCȌǤ δͲǤͲͷ Ǥ ǡ ͷȋ ȋD-HȌǡ Ǧ ȋIȌǤI ȋǣȌǡ ǡ ǡ ȏ͵ȐǤ ǡ Ǥǣ ǡȗȗȗδͲǤͲͲͳǡȗȗȗȗδͲǤͲͲͲͳǤαͺǤǤǤǤ Ǥ ͳ Ǥ ʹ Ǥ. Ǧ Ǧ ǡ ǡ Ǥ . Zooming into an MCAD-KO mouse with a severe liver phenotype ǡ ǡ Ǥ ȋ ȏ͵ȐȌ Ǥ ǡ ȋͳͲȌȋi.e.. ͳ͵ͷ.
(27) Chapter 4 Ȍȋ ͷͶȌ Ǧ Ǥ ͳͲǡ ȋ ͶȌ ȋͶȌ ǦǤͳͲ ȋͳͺǤͶȌ ȋʹͳǤ͵ ιȌǤ Ǧ Ǧ ȋ ǤȌ ͳͲ Ǧ ȋ ͷȌǤ ǡ ǡ Ǥ Ǥ
(28) ǡ ǡ Ǧ ǡ Ǥ ǡ Ǧ Ǥ ǡ ΪǤ Ϊ Ǥ . Discussion
(29) ǡ Ǧ ǡ ǤǡǦ Ǥ Ǧ ȏǤScientific Reportsǡ Ȑǡ Ǧ Ǧ ȋǡ ǡȌ Ǥ Ȃ Ȃ Ǧ Ǥ
(30) ȏͳͲȐǡ ǡ Ǥ ǡ ǡǦ Ǧ ǡ ǡ ǦͳͶ Ǥ
(31) Ǥ Ǥ ǡ Ǥ ǡ ǦȏͳͶȂͳǡʹͲȐǤ ǡǡ ȏ͵ͺȐȏ͵ͻȐǦǤ ǡ ȏͳͻǡʹͲȐǤ ǤȏͳͻǡʹͲȐ Ǥ. ͳ͵.
(32) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice. A. H&E. ORO. KO typical KO severe (KO10). 4. B. Ń Severe (KO10). . Figure 5. KO individual with extreme phenotype. ȋͳͲȌȋAȌ ͺǦǦ ȋBȌǤ ȋȌȋȌǤ. . ͳ͵.
(33) Chapter 4
(34) ǡ Ǧ Ǥ Ǧ ȏͳͻǡʹͲȐǤ
(35) ǡMcad Ǧ Ǥ
(36) ǡ Mcad ǤǦ Mcad- ǡ ǡ Acadvl, Acadl and AcadmǡǦǦ ǦȏʹʹȐǤ Ȃ ȋͳǦȌȂ Ǧ Ǥ ȋ ͳ ȌǤ
(37) ǡ Ǧ Ǥ Ǥ ǡ ǡ Ǥ ǡ Ǥ ȋ Ȍ Ǧ Ǥ ǡ ǡ ǡǦ ǡ ȋ ͵͵ȌǤǦ Ǧ ǡ Ǥ Ǧ ǡ Ǧ Ǥ Ǧ Ǧ ȏͳͻǡʹͲȐ Ǧ Ǥ Ǧ ǦǤ
(38) ȏͶͲȂͶʹȐǤ
(39) ǡ Ǧ ǡ Ǥ ǡ Ǧ Ǧ Ǥ Ǧ ǦǤ Ǧ Ǧ Ǥ ǡ Ǧ ȋ ʹǦȌǤ Ǧ ȏͳͻǡʹͲȐ Ǧ Ǧ Ǥ
(40) ǡ Ǧ ǡ ǡ Ǧ ȏͶ͵Ȑǡ Ǧ Ǧ Ǥǡ ǡ ǦͳͶ ȋ ͶǦ ȌǤ
(41) Ǧ ǤǦͳͲ Ǧ ͳ͵ͺ.
(42) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice Ǥ ͳʹǦͳͶ ǦͳͲ Ǥ ǡ Ǥ Ǧ Ǧ ǡ Ǥǡ ǡ ȏͶͶȐǤ
(43) ȏͳǡȂͻȐǤǡǡ Ǥ ȏͺǡ͵ͲǡͶͷȐǡ Ǥ ǡ ǦͳͲȋͳͲȌǤ Ǥ ȋ ȌǤͳͲ Ǥ ǡ ȏͶȐǤǡ Ǧ Ǧ ǡ ͳͲǡ Ǥ ǡͳͲ Ǥ ǡ Ǥ ǡǡ Ǧ Ǥ Ǧ Ǧ Ǥ Ǧ ȏͳͻǡʹͲȐǤ Ȁ ǡ ǡ Ǧ ȏͶͲȂͶʹȐǤ. Materials and Methods Animals, Experimental design and Tissue sampling ǦǦȋȌ ͷȀ ȋ ͳͲ ȏͶȐȌǦȋʹͳιȌǦ Ǥ ͳǦʹͲ ȋ Ȍͺȋ ȌǤ Ǥ ǡ ǦǦ ȋͳʹͶͷͲǡ ǡǡȌͶǦǡ Ǥ ǡ ͳͶ ͷι ͶǦǤ Ǥ ǡ
(44) ȋ
(45) ǡ. ͳ͵ͻ. 4.
(46) Chapter 4 ǡ Ȍ Ȁ ȋʹ ȀȌǤ ǡ ȋ
(47) ǡǡ ǡȌǤ ǡ ̺ȋ ǡǡȌ ȋ Ȍǡ Ǥ ǡǡ Ǧ Ǣ ͳͲΨ Ǧ̺ǤǡͳͶ ȋǤǤ Ȍȋ ȌǤ . Metabolite analysis ǡ Ǧ Ǥ ʹͲΨȋȀȌȋ ǤͶȌǤ ȏͶͺȐǡʹΨǦͳͲͲ ȋ ǡ ǡ Ȍ ǯ Ǥ Ǧ et al. ȏͶͻȐǤ Ǧ et al. ȏͷͲȐǤ ȋ ǡ ȌǤ . Liver lipid extraction ͲǤͻΨʹͲΨȋȀȌǤ ȋ ǡ ǡ Ȍ Ǥ
(48) Ͷ ȋͳͶǣͲȌǡ ȋͳͶǣͲȌǡȋͳǣͳȌǡ ȋͳǣͲȀͳǣͲȌǡ ȋʹ͵ǣͲȀʹ͵ǣͲȌǡ ȋͳͶǣͲȀͳͶǣͲȌǡ ȋͳǣͲȀͳǣͲȌǡ ȋͳǣͲȀͳǣͲȌǡ ȋͳǣͲȀͳǣͲȌǡ ȋͳͶǣͲȌͶǡ ȋͳͻǣʹȀͳͻǣʹȀͳͻǣʹȌǡ ȋͳǣͲȌǡ ȋͳͶǣͲȌͺ ȋͳͶǣͲȌǤ
(49) ʹͲͲɊ ͵ǣ ȋͳǣͳǡȀȌ Ǧ Ͷͷι ǤȋͷͲɊ γͳͲȌ ǦǤ ȏͷͳȐ Ǥ
(50) ǡ ͵ͲͲ Ɋ ͷͲ Ɋ Ǧ ͷ Ǥ ǡͳͲͲͲ Ɋ ͻͲͲ ʹͲǤ ͵ͲͲͲͳͲ ǤȋͻͲͲɊȌǤǦ ͲͲɊȀ Ȁ ʹȋͳͲǣ͵ǣʹǤͷǡȀȀȌǤ ͳͶͲͲɊ ͶͷιǤ ͵Ȁ ȋͳǣͳǡȀȌ ǦǤ . LC-MS measurement ͵ͲͲͲ ȋ Ȍ Ǧ ȋȌ ȋ ǡ ǡȌǤ ȏͷʹȐǤ Ȁ ȀͷͲΫͳͷͲǤ ͳͲȀ ̱ͳǤʹǤ ͲǡͲͲͲ ͳǡͷͲͲ ǡ Ǥ ǣ ͳͷͲ ιǡǣ͵Ǥͷǡ ǣ͵ͲͲιǤ . ͳͶͲ.
(51) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice Lipidomic data analysis ̺ ȋ ͵ǤʹǤ͵ ȋ ǡ ǡ Ȍ Ǥ
(52) ̺ ȋ ǡ ǡ Ȍ ǡ Ǧ Ǥ ʹͲͲǡͲͲͲ Ǥ ȋ ǡ ǡ Ȍ ȋδͷȌǡ ǡ ǡȀ ǦǤǦ ʹȏͷ͵Ȑ ȋ ͷȌǤ Ǥ
(53) ǡ Ǥ ȋȌ ȏͷͶȐǤ . Histology Ǧ ǡǤ ǡǦ̺ ǦǦǤ ȋ Ȍ ǤȏͷͷȐǤ . Statistical analysis ǡ ǡ ȋǯǦ Ȍ ȋȌǤ ǡǦǤ Ǧ ǯǦ Ǥ δͲǤͲͷ Ǥ ȋʹʹȌ ȋ
(54) Ǥǡ ͷǤͲͲǡʹͲͲȌȏͷͶȐǤ . Author contributions ǡǡ ǡ ǡ Ǥ ǡ Ǥ ǡǡ ǡ ǡǡǡǡǡ Ǥ ǡ Ǥ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ Ǥ ǡ ǡ ǡ Ǥ Ǥ . Acknowledgements Ǥ ǡ ǡ ǡ Ǥ Ǥ Ǥ . Declaration of Interests Ǥ . References ͳǤ. ǡ ǡ Ǥ Ǥ Ǥ ʹͲͲʹǢͶȋͳȌǣͶȂͷͲʹǤ. ͳͶͳ. 4.
(55) Chapter 4 ʹǤ. ͵Ǥ. ͶǤ ͷǤ Ǥ Ǥ ͺǤ ͻǤ ͳͲǤ. ͳͳǤ. ͳʹǤ. ͳ͵Ǥ ͳͶǤ ͳͷǤ. ͳǤ. ͳǤ. ͳͺǤ ͳͻǤ. ͳͶʹ. ǡ ǡ Ǥǡ Ǥ ȾǦ
(56) Ǥ Ǥ ʹͲͳǢͺȋͳȌǣʹ͵ȂͶͶǤ ǡ ǡò
(57) ǡ ǡ
(58) ǡ ǡ ǡ. ǡ Ǥ Ǧ ǤʹͲͳͺǢ ǡ ǡ ǡ ǡǡ Ǥ Ǥ ǤʹͲͲǢͳȋͳȌǣͷȂͳͳǤ Ǥ ǣ Ǥ
(59) ǤʹͲͲͻǢ͵ʹȋʹȌǣʹͳͶȂǤ Ǥ Ǥ
(60) Ǥ ʹͲͳͲǢ͵͵ȋͷȌǣͷ͵͵ȂǤ Ǥ Ǧ ǣ Ǥ Ǥ ʹͲͳǢʹ͵ȋͳȌǣͷͳȂͷǤ ǤǡǤ ǣ Ǥ
(61) ǤʹͲͳͲǢ͵͵ȋͷȌǣͷͳ͵ȂʹͲǤ ǦǤ ǡǤʹͲͳͶǤ ǡ ǡǡ ǡ ǡǡǡ ǡǤ Ǧ Ǧ Ǧ Ǥ Ǥ ʹͲͲͷǢͳȋʹȌǣͲʹͲͷȂͳʹǤ ǡǦǡ ǡǡ ǡ ǡǦ ǡ Ǧǡ ǡ ǡ ǡǦ ǡ ǡǤ ǣ Ǧ ǤǤʹͲͳǢͳͶȋͳȌǣͳͲǤ ǡ ǡ ǡǡ ǡ ǡ ǡǫǫǡ. ǡ ǡ Ǥ Ǧ Ǧ ȋȌǦ Ǥ ǤʹͲͲͺǢͶȋȌǣͳͺͻͶȂͻͲͶǤ ǡǤ ǣ Ǥ
(62) ǤʹͲͳͲǢ͵͵ȋͷȌǣͷ͵ͻȂͶǤ ǡ± ǡǡ Ǥ Ǥ ǤͳͻͺͻǢʹͷȋͳʹȌǣͻȂͳͲͳǤ ×Ǧ ǡ Ǧ× ǡǡ ǡ
(63) ǡǤ Ǥ Ǧ Ǥ ǤͳͻͺͺǢʹͷʹȋ͵ȌǣͺͶ͵ȂͻǤ ǡǡǡ ǡ ǡ ǡ ǡ ǡ ǡ. ǡǡǡ ǡ ǡǡ Ǥ Ǧ
(64) ǤǤʹͲͳͺǢʹȋȌǣͳ͵ͶͺǦͳ͵ͷͷǤͶǤ ǡǡǡ ǡ
(65) ǡ ǡ ǡ
(66) ǡ ǡ ǡ ò ǡ ǡ ǡ ǡ ǡ ǡǡ Ǥ Ǥ ǤʹͲͳͳǢͳȋʹȌǣʹͲͲȂǤ ǡǡǤ ǦǤ ǤʹͲͳǢʹͶͻȋ͵ȌǣʹͺͳȂǤ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ
(67) ǡ ǡ ǡǡǡ ǡ ǡ ǡ ǡ Ǥ.
(68) Ǧ ǤǤʹͲͳǢʹȋ͵ȌǣͷͲͻǦͷʹʹǤǤ.
(69) Effect of fasting and cold stress on hepatic metabolism in MCAD-KO mice ʹͲǤ ʹͳǤ. ʹʹǤ. ʹ͵Ǥ. ʹͶǤ. ʹͷǤ. ʹǤ ʹǤ. ʹͺǤ. ʹͻǤ ͵ͲǤ. ͵ͳǤ ͵ʹǤ ͵͵Ǥ ͵ͶǤ. ͵ͷǤ ͵Ǥ. ͵Ǥ. Ǥ ǤǤʹͲͳǢʹȋ͵ȌǣͶͷͶȂͷǤ. ǡ ǡǡ ǡ ǡǡ ǡ ǡ ǡǡ Ǥ Ǥ ǤʹͲͳͺǢʹ͵ͺȋʹȌǣͻͳȂͳͲǤ. ǡǡǤ Ǧ ǦȽ ǦǦ Ǥ ǤʹͲͲͷǢͺͶȋͳȌǣ͵ͻȂͶǤ ǡǡǡ ǡ ǡǤǦ
GERELATEERDE DOCUMENTEN
The effects of mitochondrial DNA (mtDNA) methylation on mitochondrial gene expression points to a layer of epigenetic regulation that may play a role in disease initiation
Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine: from computational model to mice to man..
Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine Martines, Anne-Claire.. IMPORTANT NOTE: You are advised to consult the publisher's
B Published model No prom CPT2 No prom VLCAD No prom LCAD No prom MCAD No prom SCAD No prom CROT No prom MSCHAD No prom MCKAT No prom MTP No promiscuity.. Published
HF Fe ͳǤͲ ͷǤͳ ͳǤ͵ ͲǤͲ ͷǤ͵ ͵Ǥͺ ͳǤͶ ͳǤͻ ͲǤͺ ͵Ǥ ͶǤͲ ͲǤͲ ʹǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͳǤͺ ʹǤʹ ʹǤͳ ͲǤͲ ʹǤ͵ ͲǤͲ ͲǤ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ Ǥͳ ͵ǤͶ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ʹǤͲ ͲǤͲ ͲǤͲ ͷǤͳ
Flux control coefficients of model with ACS knockdown to 1% of its reference value JNAD production JCPT1C16 [CoASH]MAT [palmitoyl-CoA]CYT ʹͷɊ ͳͲͲɊ ʹͷɊ ͳͲͲɊ ʹͷɊ ͳͲͲɊ
of Pediatrics, Center of Liver, Digestive and Metabolic Diseases, University of Groningen, Groningen, University Medical Center Groningen, Groningen, The Netherlands, 2 Department
Computational rat dynamic model of isolated mFAO with C16-specific CPT1 solid lines, with C16-C4 sensitive CPT1 dashed lines and with C16-C4 sensitive CPT1 at twice larger Vmax